AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Epimmune earns milestone payment under cancer epitope license.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a license granted to Anosys in August 2001.
In addition, the company announced it had received payment of an additional license fee under the terms of the original agreement as a result of Epimmune regaining all rights to the technology covered by the agreement in Japan. In the event Anosys elects to exercise its rights to include Japan in the territory covered by the agreement, Epimmune will be entitled to an additional license fee payment. The amounts of the milestone payment and additional license fee were not disclosed.
In August 2001, Epimmune granted Anosys a nonexclusive license to certain cancer epitopes and its PADRE technology for ...
- Epimmune Earns Milestone Payment Under Cancer Epitope License to Anosys.
- Press release article from: PR Newswire September 9, 2003 700+ words
...earned and received a milestone payment from Anosys Inc. as a result...Japan. In the event Anosys elects to exercise...The amounts of the milestone payment and additional license...Epimmune granted Anosys a non-exclusive...
- Chromos to acquire Anosys, Inc.
- Press release article from: PR Newswire March 15, 2005 700+ words
...it has entered into a Letter of Intent to acquire Anosys Inc. ("Anosys"). Chromos will issue shares, warrants and / or convertible notes to acquire all outstanding shares of Anosys. Chromos expects to finalize a definitive agreement...
- Epimmune and Anosys Announce Definitive Merger Agreement.
- Press release article from: PR Newswire May 12, 2003 700+ words
Epimmune Inc. and Anosys, Inc. today announced that they have...Epimmune will merge with privately-held Anosys in a strategic transaction that will...Under the terms of the agreement, all of Anosys' common and preferred stock will be...
- Anosys Announces First U.S. Patent for Exosome Technology, A New Approach to...
- Press release article from: Business Wire February 13, 2004 700+ words
...BUSINESS WIRE)--Feb. 13, 2004 Anosys, Inc. today announced that the United...diagnostics for a broad range of diseases. Anosys' most advanced, exosome-based program...Europe in advanced melanoma patients. Anosys anticipates initiating in the first half...
- Cancer Vaccine Developed by Anosys Demonstrates Positive Results in Melanoma...
- Press release article from: Business Wire October 21, 2002 700+ words
...BUSINESS WIRE)--Oct. 21, 2002 Anosys, Inc. today reported Phase I clinical trial results of Anosys' proprietary cancer vaccine for the treatment...advanced-stage melanoma were treated with Anosys' acellular anticancer dexosomes, delivery...
- Epimmune Enters Agreement For $13.5M Stock Merger With Anosys.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...Writer Epimmune Inc.'s merger with Anosys Inc. appears to be coming to fruition...combining its epitope technology with Anosys' exosome delivery technology to create...runs much longer, as Epimmune granted to Anosys a nonexclusive license to certain cancer...
- EPIMMUNE, ANOSYS NIXED MERGER CAUSED BY UNSATISFIED CONDITIONS.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron August 14, 2003 700+ words
...Inc. canceled its merger agreement with Anosys Inc., a deal first reported three months...conditions were not there at the end." Anosys co-founder Jean-Bernard Le Pecq...the cancelled union. When Epimmune and Anosys announced the merger agreement, the companies...
- Epimmune, Anosys Nixed Merger Caused By Unsatisfied Conditions.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...Inc. canceled its merger agreement with Anosys Inc., a deal first reported three months...conditions were not there at the end." Anosys co-founder Jean-Bernard Le Pecq...the cancelled union. When Epimmune and Anosys announced the merger agreement, the companies...
Source: HighBeam Research, Epimmune earns milestone payment under cancer epitope license.